Answers are grounded in this paper and cite their sources.
Biomarker evaluation observes the prognostic significance of neutrophil-to-lymphocyte ratio and CA 19-9 in pancreatic cancer, suggesting combined inflammatory and tumor profiling.
Traditionally, serum carbohydrate antigen 19-9 (CA 19-9) has been used as a key biomarker for pancreatic cancer and recently other biomarkers which reflect the systemic immune and inflammatory responses also have been explored as potential prognostic factors. The study aims to evaluate the significance of pretreatment neutrophil-to-lymphocyte ratio (NLR) and serum CA 19-9 as prognostic factor in pancreatic cancer patients.
No takes yet. Share an insight, caveat, or question.
García‐Herrera et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: